Prognostic relevance of bone marrow immune cell fractions in newly diagnosed B-cell non-Hodgkin lymphoma patients-Reference-Cited by-同舟云学术

Prognostic relevance of bone marrow immune cell fractions in newly diagnosed B-cell non-Hodgkin lymphoma patients

Published:2025-04-15 Issue:1 Volume:57 Page:
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Valvano Luciana¹,Vilella Rocchina¹,D’Auria Fiorella²,D’Arena Giovanni³,Libonati Rossana¹,Soda Michela¹,Telesca Alessia¹,Pietrantuono Giuseppe⁴,Mansueto Giovanna Rosaria⁴,Villani Oreste⁴,D’Agostino Simona⁴,Calice Giovanni⁵,Statuto Teodora¹

Affiliation:

1. Laboratory of Clinical Research and Advanced Diagnostics, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB)

2. Laboratory of Clinical Pathology, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB)

3. Hematology, “S. Luca” Hospital, ASL Salerno

4. Hematology and Stem Cell Transplantation Unit, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB)

5. Laboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB)

Funder

Italian Minister of Health - Ricerca Corrente 2024

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2025.2490825

Reference54 articles.

1. Cellular Therapy Updates in B-Cell Lymphoma: The State of the CAR-T

2. From the R.E.A.L. Classification to the upcoming WHO scheme: A step toward universal categorization of lymphoma entities?

3. Lymphoma classification – from controversy to consensus: The R.E.A.L. and WHO Classification of lymphoid neoplasms

4. Advances in the treatment of relapsed/refractory marginal zone lymphoma

5. Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review